These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36764305)

  • 1. Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration.
    Kelty TJ; Dashek RJ; Arnold WD; Rector RS
    Semin Liver Dis; 2023 Feb; 43(1):77-88. PubMed ID: 36764305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review.
    Giuffrè M; Merli N; Pugliatti M; Moretti R
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
    Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
    J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?
    Gehrke N; Schattenberg JM
    Gastroenterology; 2020 May; 158(7):1929-1947.e6. PubMed ID: 32068022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
    Lim S; Oh TJ; Koh KK
    Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic aspects of adult patients with nonalcoholic fatty liver disease.
    Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A
    World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial.
    Chen Y; Feng R; Yang X; Dai J; Huang M; Ji X; Li Y; Okekunle AP; Gao G; Onwuka JU; Pang X; Wang C; Li C; Li Y; Sun C
    Am J Clin Nutr; 2019 Jun; 109(6):1611-1619. PubMed ID: 31136662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental Microcystin exposure in underlying NAFLD-induced exacerbation of neuroinflammation, blood-brain barrier dysfunction, and neurodegeneration are NLRP3 and S100B dependent.
    Mondal A; Saha P; Bose D; Chatterjee S; Seth RK; Xiao S; Porter DE; Brooks BW; Scott GI; Nagarkatti M; Nagarkatti P; Chatterjee S
    Toxicology; 2021 Sep; 461():152901. PubMed ID: 34416350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.
    Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ
    Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.
    Santos RD; Valenti L; Romeo S
    Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis.
    Xu X; Lu L; Dong Q; Li X; Zhang N; Xin Y; Xuan S
    Lipids Health Dis; 2015 Dec; 14():158. PubMed ID: 26631018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.
    Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH).
    Ota T
    Adv Exp Med Biol; 2021; 1261():223-229. PubMed ID: 33783745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease and dyslipidemia: An update.
    Katsiki N; Mikhailidis DP; Mantzoros CS
    Metabolism; 2016 Aug; 65(8):1109-23. PubMed ID: 27237577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of nonalcoholic fatty liver disease-related metabolic state on depression.
    Ntona S; Papaefthymiou A; Kountouras J; Gialamprinou D; Kotronis G; Boziki M; Polyzos SA; Tzitiridou M; Chatzopoulos D; Thavayogarajah T; Gkolia I; Ntonas G; Vardaka E; Doulberis M
    Neurochem Int; 2023 Feb; 163():105484. PubMed ID: 36634820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro.
    Mey JT; Erickson ML; Axelrod CL; King WT; Flask CA; McCullough AJ; Kirwan JP
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E187-E195. PubMed ID: 32396388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease.
    Negi CK; Khan S; Dirven H; Bajard L; Bláha L
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats.
    El-Deen RM; Heeba GH; Abdel-Latif RG; Khalifa MMA
    Fundam Clin Pharmacol; 2020 Jun; 34(3):353-364. PubMed ID: 31885103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.